Scientists thought there was little left to learn about a class of medications that includes ibuprofen, but a recent discovery raises the possibility of a new class of pain relievers. Ibuprofen, naproxen, and related non-steroidal anti-inflammatory drugs, known as NSAIDs, have been the subject of years of study. Researchers from Vanderbilt University report this week in the journal Nature Chemical Biology new insights into how NSAIDs work to block the activity of the cyclooxygenase enzymes, COX-1 and COX-2.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.